-
1
-
-
77956738766
-
Intralesional chemotherapy for nonmelanoma skin cancer: A practical review
-
Kirby JS, Miller CJ,. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review. J Am Acad Dermatol 2010; 63: 689-702.
-
(2010)
J Am Acad Dermatol
, vol.63
, pp. 689-702
-
-
Kirby, J.S.1
Miller, C.J.2
-
2
-
-
79954562903
-
Lasers in the treatment of nonmelanoma skin cancer
-
Choudhary S, Tang J, Elsaie ML, Nouri K,. Lasers in the treatment of nonmelanoma skin cancer. Dermatol Surg 2011; 37: 409-25.
-
(2011)
Dermatol Surg
, vol.37
, pp. 409-425
-
-
Choudhary, S.1
Tang, J.2
Elsaie, M.L.3
Nouri, K.4
-
3
-
-
0141842584
-
Immunotherapy of basal cell carcinoma: Evolving approaches
-
Gaspari AA, Sauder DN,. Immunotherapy of basal cell carcinoma: evolving approaches. Dermatol Surg 2003; 29: 1027-34.
-
(2003)
Dermatol Surg
, vol.29
, pp. 1027-1034
-
-
Gaspari, A.A.1
Sauder, D.N.2
-
5
-
-
0035028717
-
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial
-
Marks R, Gebauer K, Shumack S, Amies M, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44: 807-13.
-
(2001)
J Am Acad Dermatol
, vol.44
, pp. 807-813
-
-
Marks, R.1
Gebauer, K.2
Shumack, S.3
Amies, M.4
-
6
-
-
0036786195
-
An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream
-
Cowen E, Mercurio MG, Gaspari AA,. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. J Am Acad Dermatol 2002; 47: S240-8.
-
(2002)
J Am Acad Dermatol
, vol.47
-
-
Cowen, E.1
Mercurio, M.G.2
Gaspari, A.A.3
-
7
-
-
0036737628
-
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study
-
Geisse JK, Rich P, Pandya A, Gross K, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002; 47: 390-8.
-
(2002)
J Am Acad Dermatol
, vol.47
, pp. 390-398
-
-
Geisse, J.K.1
Rich, P.2
Pandya, A.3
Gross, K.4
-
8
-
-
0036886426
-
Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: Randomized studies comparing low-frequency dosing with and without occlusion
-
Sterry W, Ruzicka T, Herrera E, Takwale A, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002; 147: 1227-36.
-
(2002)
Br J Dermatol
, vol.147
, pp. 1227-1236
-
-
Sterry, W.1
Ruzicka, T.2
Herrera, E.3
Takwale, A.4
-
9
-
-
1842586450
-
Superficial and nodular basal cell carcinomas treated with an immune response modifier: A report of seven patients
-
Bianchi L, Costanzo A, Campione E, Nistico S, et al. Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients. Clin Exp Dermatol 2003; 28 (Suppl 1): 24-6.
-
(2003)
Clin Exp Dermatol
, vol.28
, Issue.SUPPL. 1
, pp. 24-26
-
-
Bianchi, L.1
Costanzo, A.2
Campione, E.3
Nistico, S.4
-
10
-
-
2342473348
-
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies
-
Geisse J, Caro I, Lindholm J, Golitz L, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-33.
-
(2004)
J Am Acad Dermatol
, vol.50
, pp. 722-733
-
-
Geisse, J.1
Caro, I.2
Lindholm, J.3
Golitz, L.4
-
11
-
-
5444228183
-
Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas
-
Marks R, Owens M, Walters SA,. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas. Arch Dermatol 2004; 140: 1284-5.
-
(2004)
Arch Dermatol
, vol.140
, pp. 1284-1285
-
-
Marks, R.1
Owens, M.2
Walters, S.A.3
-
12
-
-
5444266559
-
5% imiquimod cream for the treatment of large superficial basal cell carcinoma
-
Shumack S, Gebauer K, Quirk C, Macdonald K, et al. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Arch Dermatol 2004; 140: 1286-7.
-
(2004)
Arch Dermatol
, vol.140
, pp. 1286-1287
-
-
Shumack, S.1
Gebauer, K.2
Quirk, C.3
Macdonald, K.4
-
13
-
-
18244384077
-
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial
-
Peris K, Campione E, Micantonio T, Marulli GC, et al. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg 2005; 31: 318-23.
-
(2005)
Dermatol Surg
, vol.31
, pp. 318-323
-
-
Peris, K.1
Campione, E.2
Micantonio, T.3
Marulli, G.C.4
-
14
-
-
18944395052
-
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from a randomized vehicle-controlled phase III study in Europe
-
Schulze HJ, Cribier B, Requena L, Reifenberger J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005; 152: 939-47.
-
(2005)
Br J Dermatol
, vol.152
, pp. 939-947
-
-
Schulze, H.J.1
Cribier, B.2
Requena, L.3
Reifenberger, J.4
-
15
-
-
33745744243
-
Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: A 3-year retrospective follow-up study
-
Vun Y, Siller G,. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study. Australas J Dermatol 2006; 47: 169-71.
-
(2006)
Australas J Dermatol
, vol.47
, pp. 169-171
-
-
Vun, Y.1
Siller, G.2
-
16
-
-
34548787163
-
Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: Histological and clinical changes, outcome, and follow-up
-
Schiessl C, Wolber C, Tauber M, Offner F, et al. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up. J Drugs Dermatol 2007; 6: 507-13.
-
(2007)
J Drugs Dermatol
, vol.6
, pp. 507-513
-
-
Schiessl, C.1
Wolber, C.2
Tauber, M.3
Offner, F.4
-
17
-
-
33847145490
-
Fifty-five basal cell carcinomas treated with topical imiquimod: Outcome at 5-year follow-up
-
Vidal D, Matias-Guiu X, Alomar A,. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. Arch Dermatol 2007; 143: 266-8.
-
(2007)
Arch Dermatol
, vol.143
, pp. 266-268
-
-
Vidal, D.1
Matias-Guiu, X.2
Alomar, A.3
-
18
-
-
57749201993
-
Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: Conclusion of a 5-year long-term follow-up study in Europe
-
Gollnick H, Barona CG, Frank RG, Ruzicka T, et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol 2008; 18: 677-82.
-
(2008)
Eur J Dermatol
, vol.18
, pp. 677-682
-
-
Gollnick, H.1
Barona, C.G.2
Frank, R.G.3
Ruzicka, T.4
-
19
-
-
77955778580
-
Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: Results of a prospective 5-year study
-
Quirk C, Gebauer K, De'Ambrosis B, Slade HB, et al. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis 2010; 85: 318-24.
-
(2010)
Cutis
, vol.85
, pp. 318-324
-
-
Quirk, C.1
Gebauer, K.2
De'Ambrosis, B.3
Slade, H.B.4
-
20
-
-
84883555820
-
-
Valeant Pharmaceuticals International. Costa Mesa (CA): Valeant Pharmaceuticals International
-
Valeant Pharmaceuticals International. Efudex-40™ (fluorouracil topical cream) prescribing information. Costa Mesa (CA): Valeant Pharmaceuticals International; 2004.
-
(2004)
Efudex-40™ (Fluorouracil Topical Cream) Prescribing Information
-
-
-
21
-
-
34147123685
-
5% 5-fluorouracil cream for the treatment of small superficial Basal cell carcinoma: Efficacy, tolerability, cosmetic outcome, and patient satisfaction
-
discussion 40
-
Gross K, Kircik L,. 5% 5-fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007; 33: 433-9; discussion 40.
-
(2007)
Dermatol Surg
, vol.33
, pp. 433-439
-
-
Gross, K.1
Kircik, L.2
-
22
-
-
0036715342
-
Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens
-
Shumack S, Robinson J, Kossard S, Golitz L, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 2002; 138: 1165-71.
-
(2002)
Arch Dermatol
, vol.138
, pp. 1165-1171
-
-
Shumack, S.1
Robinson, J.2
Kossard, S.3
Golitz, L.4
-
23
-
-
1942504386
-
Topical imiquimod treatment for nodular basal cell carcinomas: An open-label series
-
Huber A, Huber JD, Skinner RB Jr, Kuwahara RT, et al. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series. Dermatol Surg 2004; 30: 429-30.
-
(2004)
Dermatol Surg
, vol.30
, pp. 429-430
-
-
Huber, A.1
Huber, J.D.2
Skinner, Jr.R.B.3
Kuwahara, R.T.4
-
24
-
-
34548531036
-
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma
-
Eigentler TK, Kamin A, Weide BM, Breuninger H, et al. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol 2007; 57: 616-21.
-
(2007)
J Am Acad Dermatol
, vol.57
, pp. 616-621
-
-
Eigentler, T.K.1
Kamin, A.2
Weide, B.M.3
Breuninger, H.4
-
25
-
-
34547394778
-
Imiquimod in the treatment of eyelid basal cell carcinoma
-
Leppala J, Kaarniranta K, Uusitalo H, Kontkanen M,. Imiquimod in the treatment of eyelid basal cell carcinoma. Acta Ophthalmol Scand 2007; 85: 566-8.
-
(2007)
Acta Ophthalmol Scand
, vol.85
, pp. 566-568
-
-
Leppala, J.1
Kaarniranta, K.2
Uusitalo, H.3
Kontkanen, M.4
-
26
-
-
0035102498
-
Imiquimod 5% cream in the treatment of Bowen's disease
-
Mackenzie-Wood A, Kossard S, de Launey J, Wilkinson B, et al. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001; 44: 462-70.
-
(2001)
J Am Acad Dermatol
, vol.44
, pp. 462-470
-
-
Mackenzie-Wood, A.1
Kossard, S.2
De Launey, J.3
Wilkinson, B.4
-
27
-
-
1642416709
-
Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients
-
Prinz BM, Hafner J, Dummer R, Burg G, et al. Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients. Transplantation 2004; 77: 790-1.
-
(2004)
Transplantation
, vol.77
, pp. 790-791
-
-
Prinz, B.M.1
Hafner, J.2
Dummer, R.3
Burg, G.4
-
28
-
-
15944371467
-
Imiquimod 5% cream: A new treatment for Bowen's disease
-
Mandekou-Lefaki I, Delli F, Koussidou-Eremondi T, Mourellou-Tsatsou O, et al. Imiquimod 5% cream: a new treatment for Bowen's disease. Int J Tissue React 2005; 27: 31-8.
-
(2005)
Int J Tissue React
, vol.27
, pp. 31-38
-
-
Mandekou-Lefaki, I.1
Delli, F.2
Koussidou-Eremondi, T.3
Mourellou-Tsatsou, O.4
-
29
-
-
33646531439
-
Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomized, double-blind, placebo-controlled trial
-
Patel GK, Goodwin R, Chawla M, Laidler P, et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2006; 54: 1025-32.
-
(2006)
J Am Acad Dermatol
, vol.54
, pp. 1025-1032
-
-
Patel, G.K.1
Goodwin, R.2
Chawla, M.3
Laidler, P.4
-
30
-
-
33745843689
-
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma
-
Peris K, Micantonio T, Fargnoli MC, Lozzi GP, et al. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. J Am Acad Dermatol 2006; 55: 324-7.
-
(2006)
J Am Acad Dermatol
, vol.55
, pp. 324-327
-
-
Peris, K.1
Micantonio, T.2
Fargnoli, M.C.3
Lozzi, G.P.4
-
31
-
-
34147137132
-
Treatment of Bowen's disease with topical 5% imiquimod cream: Retrospective study
-
discussion 31-2
-
Rosen T, Harting M, Gibson M,. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. Dermatol Surg 2007; 33: 427-31; discussion 31-2.
-
(2007)
Dermatol Surg
, vol.33
, pp. 427-431
-
-
Rosen, T.1
Harting, M.2
Gibson, M.3
-
32
-
-
80052084693
-
Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report
-
Jeon HC, Choi M, Paik SH, Ahn CH, et al. Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report. Ann Dermatol 2011; 23: 357-61.
-
(2011)
Ann Dermatol
, vol.23
, pp. 357-361
-
-
Jeon, H.C.1
Choi, M.2
Paik, S.H.3
Ahn, C.H.4
-
33
-
-
0037366476
-
Topical treatment of Bowen's disease with 5-Fluorouracil
-
Bargman H, Hochman J,. Topical treatment of Bowen's disease with 5-Fluorouracil. J Cutan Med Surg 2003; 7: 101-5.
-
(2003)
J Cutan Med Surg
, vol.7
, pp. 101-105
-
-
Bargman, H.1
Hochman, J.2
-
34
-
-
0037362509
-
Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease
-
Salim A, Leman JA, McColl JH, Chapman R, et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003; 148: 539-43.
-
(2003)
Br J Dermatol
, vol.148
, pp. 539-543
-
-
Salim, A.1
Leman, J.A.2
McColl, J.H.3
Chapman, R.4
-
35
-
-
33745229420
-
Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial
-
Morton C, Horn M, Leman J, Tack B, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006; 142: 729-35.
-
(2006)
Arch Dermatol
, vol.142
, pp. 729-735
-
-
Morton, C.1
Horn, M.2
Leman, J.3
Tack, B.4
-
36
-
-
0017157488
-
Intradermal 5-fluorouracil in the treatment of basal cell carcinoma of the face
-
Avant WH, Huff RC,. Intradermal 5-fluorouracil in the treatment of basal cell carcinoma of the face. South Med J 1976; 69: 561-3.
-
(1976)
South Med J
, vol.69
, pp. 561-563
-
-
Avant, W.H.1
Huff, R.C.2
-
37
-
-
0018840425
-
Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU)
-
Kurtis B, Rosen T,. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU). J Dermatol Surg Oncol 1980; 6: 122-7.
-
(1980)
J Dermatol Surg Oncol
, vol.6
, pp. 122-127
-
-
Kurtis, B.1
Rosen, T.2
-
38
-
-
0002726755
-
Tumors of the skin. II. Keratoacanthoma; Local effct of 5-fluorouracil
-
Klein E, Helm F, Milgrom H, Stoll HL Jr, et al. Tumors of the skin. II. Keratoacanthoma; local effct of 5-fluorouracil. Skin (Los Angeles) 1962; 1: 153-6.
-
(1962)
Skin (Los Angeles)
, vol.1
, pp. 153-156
-
-
Klein, E.1
Helm, F.2
Milgrom, H.3
Stoll, Jr.H.L.4
-
39
-
-
0018988739
-
Successful treatment of keratoacanthoma with intralesional fluorouracil
-
Goette DK, Odom RB,. Successful treatment of keratoacanthoma with intralesional fluorouracil. J Am Acad Dermatol 1980; 2: 212-6.
-
(1980)
J Am Acad Dermatol
, vol.2
, pp. 212-216
-
-
Goette, D.K.1
Odom, R.B.2
-
40
-
-
0022651257
-
Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil
-
Parker CM, Hanke CW,. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil. J Am Acad Dermatol 1986; 14: 770-7.
-
(1986)
J Am Acad Dermatol
, vol.14
, pp. 770-777
-
-
Parker, C.M.1
Hanke, C.W.2
-
41
-
-
0025787838
-
Treatment of keratoacanthomas with intralesional methotrexate
-
Melton JL, Nelson BR, Stough DB, Brown MD, et al. Treatment of keratoacanthomas with intralesional methotrexate. J Am Acad Dermatol 1991; 25: 1017-23.
-
(1991)
J Am Acad Dermatol
, vol.25
, pp. 1017-1023
-
-
Melton, J.L.1
Nelson, B.R.2
Stough, D.B.3
Brown, M.D.4
-
42
-
-
0031957639
-
Intralesional methotrexate in solitary keratoacanthoma
-
Cuesta-Romero C, de Grado-Pena J,. Intralesional methotrexate in solitary keratoacanthoma. Arch Dermatol 1998; 134: 513-4.
-
(1998)
Arch Dermatol
, vol.134
, pp. 513-514
-
-
Cuesta-Romero, C.1
De Grado-Pena, J.2
-
43
-
-
34248140144
-
Intralesional methotrexate treatment for keratoacanthoma tumors: A retrospective study and review of the literature
-
Annest NM, VanBeek MJ, Arpey CJ, Whitaker DC,. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J Am Acad Dermatol 2007; 56: 989-93.
-
(2007)
J Am Acad Dermatol
, vol.56
, pp. 989-993
-
-
Annest, N.M.1
Vanbeek, M.J.2
Arpey, C.J.3
Whitaker, D.C.4
-
44
-
-
0015277479
-
Effect of bleomycin on benign and malignant cutaneous tumours
-
Mishima Y, Matunaka M,. Effect of bleomycin on benign and malignant cutaneous tumours. Acta Derm Venereol 1972; 52: 211-5.
-
(1972)
Acta Derm Venereol
, vol.52
, pp. 211-215
-
-
Mishima, Y.1
Matunaka, M.2
-
45
-
-
0020525263
-
Treatment of keratoacanthoma with intralesional bleomycin
-
Sayama S, Tagami H,. Treatment of keratoacanthoma with intralesional bleomycin. Br J Dermatol 1983; 109: 449-52.
-
(1983)
Br J Dermatol
, vol.109
, pp. 449-452
-
-
Sayama, S.1
Tagami, H.2
-
46
-
-
0022467385
-
Treatment of basal cell carcinoma with intralesional interferon
-
Greenway HT, Cornell RC, Tanner DJ, Peets E, et al. Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 1986; 15: 437-43.
-
(1986)
J Am Acad Dermatol
, vol.15
, pp. 437-443
-
-
Greenway, H.T.1
Cornell, R.C.2
Tanner, D.J.3
Peets, E.4
-
47
-
-
0024501706
-
Treatment of neoplastic skin lesions with intralesional interferon
-
Wickramasinghe L, Hindson TC, Wacks H,. Treatment of neoplastic skin lesions with intralesional interferon. J Am Acad Dermatol 1989; 20: 71-4.
-
(1989)
J Am Acad Dermatol
, vol.20
, pp. 71-74
-
-
Wickramasinghe, L.1
Hindson, T.C.2
Wacks, H.3
-
48
-
-
0023928771
-
Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a
-
Grob JJ, Collet AM, Munoz MH, Bonerandi JJ,. Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a. Lancet 1988; 1: 878-9.
-
(1988)
Lancet
, vol.1
, pp. 878-879
-
-
Grob, J.J.1
Collet, A.M.2
Munoz, M.H.3
Bonerandi, J.J.4
-
49
-
-
0029068096
-
Intralesional alfa-2a interferon therapy for basal cell carcinoma
-
Dogan B, Harmanyeri Y, Baloglu H, Oztek I,. Intralesional alfa-2a interferon therapy for basal cell carcinoma. Cancer Lett 1995; 91: 215-9.
-
(1995)
Cancer Lett
, vol.91
, pp. 215-219
-
-
Dogan, B.1
Harmanyeri, Y.2
Baloglu, H.3
Oztek, I.4
-
50
-
-
0029057234
-
Treatment of basal cell carcinoma with intralesional interferon alpha-2a
-
LeGrice P, Baird E, Hodge L,. Treatment of basal cell carcinoma with intralesional interferon alpha-2a. N Z Med J 1995; 108: 206-7.
-
(1995)
N Z Med J
, vol.108
, pp. 206-207
-
-
Legrice, P.1
Baird, E.2
Hodge, L.3
-
51
-
-
0030056075
-
Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma
-
Alpsoy E, Yilmaz E, Basaran E, Yazar S,. Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma. J Dermatol 1996; 23: 394-6.
-
(1996)
J Dermatol
, vol.23
, pp. 394-396
-
-
Alpsoy, E.1
Yilmaz, E.2
Basaran, E.3
Yazar, S.4
-
52
-
-
24944590701
-
Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon alpha-2a: Evaluation of Long-Term Follow-Up Results
-
Bostanci S, Kocyigit P, Alp A, Erdem C, et al. Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon alpha-2a: evaluation of Long-Term Follow-Up Results. Clin Drug Investig 2005; 25: 661-7.
-
(2005)
Clin Drug Investig
, vol.25
, pp. 661-667
-
-
Bostanci, S.1
Kocyigit, P.2
Alp, A.3
Erdem, C.4
-
53
-
-
0027221095
-
Large keratoacanthomas treated with intralesional interferon alfa-2a
-
Grob JJ, Suzini F, Richard MA, Weiller M, et al. Large keratoacanthomas treated with intralesional interferon alfa-2a. J Am Acad Dermatol 1993; 29: 237-41.
-
(1993)
J Am Acad Dermatol
, vol.29
, pp. 237-241
-
-
Grob, J.J.1
Suzini, F.2
Richard, M.A.3
Weiller, M.4
-
54
-
-
0025083873
-
Intralesional interferon therapy for basal cell carcinoma
-
Cornell RC, Greenway HT, Tucker SB, Edwards L, et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23: 694-700.
-
(1990)
J Am Acad Dermatol
, vol.23
, pp. 694-700
-
-
Cornell, R.C.1
Greenway, H.T.2
Tucker, S.B.3
Edwards, L.4
-
55
-
-
0025298152
-
The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas
-
Edwards L, Tucker SB, Perednia D, Smiles KA, et al. The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas. Arch Dermatol 1990; 126: 1029-32.
-
(1990)
Arch Dermatol
, vol.126
, pp. 1029-1032
-
-
Edwards, L.1
Tucker, S.B.2
Perednia, D.3
Smiles, K.A.4
-
56
-
-
0025351873
-
Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon
-
Mozzanica N, Cattaneo A, Boneschi V, Brambilla L, et al. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon. Arch Dermatol Res 1990; 282: 311-7.
-
(1990)
Arch Dermatol Res
, vol.282
, pp. 311-317
-
-
Mozzanica, N.1
Cattaneo, A.2
Boneschi, V.3
Brambilla, L.4
-
58
-
-
0026027170
-
Intralesional alpha 2b recombinant interferon for basal cell carcinomas
-
Boneschi V, Brambilla L, Chiappino G, Mozzanica N, et al. Intralesional alpha 2b recombinant interferon for basal cell carcinomas. Int J Dermatol 1991; 30: 220-4.
-
(1991)
Int J Dermatol
, vol.30
, pp. 220-224
-
-
Boneschi, V.1
Brambilla, L.2
Chiappino, G.3
Mozzanica, N.4
-
59
-
-
0025944092
-
Treatment of basal cell carcinoma with intralesional interferon alpha-2b
-
Healsmith MF, Berth-Jones J, Fletcher A, Graham-Brown RA,. Treatment of basal cell carcinoma with intralesional interferon alpha-2b. J R Soc Med 1991; 84: 524-6.
-
(1991)
J R Soc Med
, vol.84
, pp. 524-526
-
-
Healsmith, M.F.1
Berth-Jones, J.2
Fletcher, A.3
Graham-Brown, R.A.4
-
60
-
-
0028228904
-
Treatment of basal cell carcinoma with intralesional interferon alpha-2b: Evaluation of efficacy with emphasis on tumors located on 'H' zone of the face
-
Pizarro A, Fonseca E,. Treatment of basal cell carcinoma with intralesional interferon alpha-2b: evaluation of efficacy with emphasis on tumors located on 'H' zone of the face. Eur J Dermatol 1994; 4: 287-90.
-
(1994)
Eur J Dermatol
, vol.4
, pp. 287-290
-
-
Pizarro, A.1
Fonseca, E.2
-
61
-
-
0028916478
-
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma
-
Chimenti S, Peris K, Di Cristofaro S, Fargnoli MC, et al. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma. Dermatology 1995; 190: 214-7.
-
(1995)
Dermatology
, vol.190
, pp. 214-217
-
-
Chimenti, S.1
Peris, K.2
Di Cristofaro, S.3
Fargnoli, M.C.4
-
62
-
-
33646509240
-
Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy
-
Tucker SB, Polasek JW, Perri AJ, Goldsmith EA,. Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy. J Am Acad Dermatol 2006; 54: 1033-8.
-
(2006)
J Am Acad Dermatol
, vol.54
, pp. 1033-1038
-
-
Tucker, S.B.1
Polasek, J.W.2
Perri, A.J.3
Goldsmith, E.A.4
-
63
-
-
0026693223
-
Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery
-
Stenquist B, Wennberg AM, Gisslen H, Larko O,. Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery. J Am Acad Dermatol 1992; 27: 65-9.
-
(1992)
J Am Acad Dermatol
, vol.27
, pp. 65-69
-
-
Stenquist, B.1
Wennberg, A.M.2
Gisslen, H.3
Larko, O.4
-
64
-
-
0842333115
-
Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: Revisited
-
Kim KH, Yavel RM, Gross VL, Brody N,. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited. Dermatol Surg 2004; 30: 116-20.
-
(2004)
Dermatol Surg
, vol.30
, pp. 116-120
-
-
Kim, K.H.1
Yavel, R.M.2
Gross, V.L.3
Brody, N.4
-
65
-
-
16644397926
-
Intralesional interferon alfa-2b treatment of keratoacanthomas
-
Oh CK, Son HS, Lee JB, Jang HS, et al. Intralesional interferon alfa-2b treatment of keratoacanthomas. J Am Acad Dermatol 2004; 51: S177-80.
-
(2004)
J Am Acad Dermatol
, vol.51
-
-
Oh, C.K.1
Son, H.S.2
Lee, J.B.3
Jang, H.S.4
-
66
-
-
0026490144
-
Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy
-
Edwards L, Berman B, Rapini RP, Whiting DA, et al. Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy. Arch Dermatol 1992; 128: 1486-9.
-
(1992)
Arch Dermatol
, vol.128
, pp. 1486-1489
-
-
Edwards, L.1
Berman, B.2
Rapini, R.P.3
Whiting, D.A.4
-
67
-
-
0028101334
-
Treatment of basal cell carcinoma with intralesional recombinant interferon beta: A dose-finding study
-
Kowalzick L, Rogozinski T, Schober C, Fierlbeck G, et al. Treatment of basal cell carcinoma with intralesional recombinant interferon beta: a dose-finding study. Eur J Dermatol 1994; 4: 430-3.
-
(1994)
Eur J Dermatol
, vol.4
, pp. 430-433
-
-
Kowalzick, L.1
Rogozinski, T.2
Schober, C.3
Fierlbeck, G.4
-
68
-
-
0036861010
-
Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: Results of an open-label multicentre study
-
Kowalzick L, Rogozinski T, Wimheuer R, Pilz J, et al. Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study. Eur J Dermatol 2002; 12: 558-61.
-
(2002)
Eur J Dermatol
, vol.12
, pp. 558-561
-
-
Kowalzick, L.1
Rogozinski, T.2
Wimheuer, R.3
Pilz, J.4
-
69
-
-
0025314154
-
The effect of intralesional interferon gamma on basal cell carcinomas
-
Edwards L, Whiting D, Rogers D, Luck K, et al. The effect of intralesional interferon gamma on basal cell carcinomas. J Am Acad Dermatol 1990; 22: 496-500.
-
(1990)
J Am Acad Dermatol
, vol.22
, pp. 496-500
-
-
Edwards, L.1
Whiting, D.2
Rogers, D.3
Luck, K.4
-
70
-
-
0024444729
-
Intralesional treatment of basal cell carcinoma with low-dose recombinant interferon gamma
-
Tank B, Habets JM, Naafs B, Damsma O, et al. Intralesional treatment of basal cell carcinoma with low-dose recombinant interferon gamma. J Am Acad Dermatol 1989; 21: 734-5.
-
(1989)
J Am Acad Dermatol
, vol.21
, pp. 734-735
-
-
Tank, B.1
Habets, J.M.2
Naafs, B.3
Damsma, O.4
-
71
-
-
0032723959
-
Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases
-
Cribier B, Asch P, Grosshans E,. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology 1999; 199: 208-12
-
(1999)
Dermatology
, vol.199
, pp. 208-212
-
-
Cribier, B.1
Asch, P.2
Grosshans, E.3
|